Does Curcumin Sleep Randomized Trial work?

Updated July 2026

Quick Answer

Curcumin Sleep Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: 7 8 9 10 11 12 13 Pathophysiology has revealed that one of the primary risk factors for depression is chronic stress due to glucocorticoid effects on the hypothalamic–pituitary–adrenal (HPA) axis [].

Key Takeaways

  • 017 8 9 10 11 12 13 Pathophysiology has revealed that one of the primary risk factors for depression is chronic stress due to glucocorticoid effects on the hypothalamic–pituitary–adrenal (HPA) axis []. [Cavanah Aidan M. (2026)]
  • 02BDNF exerts neuroprotective and neuroactivating properties on both excitatory and inhibitory neurons, with high concentrations found in the hippocampus and frontal cortex []. [Cavanah Aidan M. (2026)]
  • 03These studies support the ‘neurotrophin hypothesis of depression’, which states that reduced levels of BDNF in the brain contribute to cell atrophy in the hippocampus and prefrontal cortex []. [Cavanah Aidan M. (2026)]
  • 041 2 3 4 5 6 Mood disorders are notable disruptions in emotions that occur internally but can impact a person’s behavior externally []. [Cavanah Aidan M. (2026)]
The current Migaku evidence database contains 2 reusable source documents for Curcumin Sleep Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - 7 8 9 10 11 12 13 Pathophysiology has revealed that one of the primary risk factors for depression is chronic stress due to glucocorticoid effects on the hypothalamic–pituitary–adrenal (HPA) axis []. [Cavanah Aidan M. (2026); evidence level 2] - BDNF exerts neuroprotective and neuroactivating properties on both excitatory and inhibitory neurons, with high concentrations found in the hippocampus and frontal cortex []. [Cavanah Aidan M. (2026); evidence level 2] - These studies support the ‘neurotrophin hypothesis of depression’, which states that reduced levels of BDNF in the brain contribute to cell atrophy in the hippocampus and prefrontal cortex []. [Cavanah Aidan M. (2026); evidence level 2] - 1 2 3 4 5 6 Mood disorders are notable disruptions in emotions that occur internally but can impact a person’s behavior externally []. [Cavanah Aidan M. (2026); evidence level 2] - Background Diabetic retinopathy (DR) is a significant complication of diabetes that can adversely affect the quality of life and anthropometric indices of individuals. [Amini S (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. A Randomized Controlled Trial to Determine the Effects of Curcumin and Epigallocatechin-3-Gallate Supplementation on Serum Brain-Derived Neurotrophic Factor and Mood Disturbance in Adults
  2. The Effect of Curcumin Plus Piperine on Mental Health Status, Sleep Quality, and Anthropometric Indices in Patients with Non-Proliferative Diabetic Retinopathy: A Randomized Double-Blind Placebo-Controlled Trial.